Literature DB >> 23297753

Tumor-stromal interactions in breast tumor progression--significance of histological heterogeneity of tumor-stromal fibroblasts.

Takahiro Hasebe1.   

Abstract

INTRODUCTION: Existing pathological diagnostic protocols for breast cancer do not fully reflect the biological characteristics of tumor stromata. To improve the pathological diagnosis of breast cancer, a new pathological diagnostic method capable of assessing the degree of breast cancer malignancy based on the histological features of the tumor stroma is needed. AREAS COVERED: The presence of a fibrotic focus (FF), which consists of fibroblasts or collagen fibers, and the presence of atypical tumor-stromal fibroblasts are significantly associated with nodal metastasis or distant-organ metastasis in patients with invasive ductal carcinoma (IDC) of the breast. FF is the only factor that is significantly associated with an increase in tumor angiogenesis. The importance of FF and atypical tumor-stromal fibroblasts clearly indicates that the malignant potential of IDC does not depend only on the biological characteristics of the tumor cell, but also on those of the tumor stroma. EXPERT OPINION: The biological characteristics of fibroblasts forming an FF or atypical tumor-stromal fibroblasts probably differ from those of fibroblasts located outside an FF or ordinary tumor-stromal fibroblasts. Thus, similar to tumor cells, the heterogeneity of tumor-stromal fibroblasts probably influences the outcome of patients with IDC of the breast.

Entities:  

Mesh:

Year:  2013        PMID: 23297753     DOI: 10.1517/14728222.2013.757305

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  8 in total

1.  Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.

Authors:  Kristen S Purrington; Daniel W Visscher; Chen Wang; Drakoulis Yannoukakos; Ute Hamann; Heli Nevanlinna; Angela Cox; Graham G Giles; Jeanette E Eckel-Passow; Sotiris Lakis; Vassiliki Kotoula; George Fountzilas; Maria Kabisch; Thomas Rüdiger; Päivi Heikkilä; Carl Blomqvist; Simon S Cross; Melissa C Southey; Janet E Olson; Judy Gilbert; Sandra Deming-Halverson; Veli-Matti Kosma; Christine Clarke; Rodney Scott; J Louise Jones; Wei Zheng; Arto Mannermaa; Diana M Eccles; Celine M Vachon; Fergus J Couch
Journal:  Breast Cancer Res Treat       Date:  2016-04-15       Impact factor: 4.872

Review 2.  Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

Authors:  Ashley H Davis-Yadley; Mokenge P Malafa
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

3.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.

Authors:  I Acerbi; L Cassereau; I Dean; Q Shi; A Au; C Park; Y Y Chen; J Liphardt; E S Hwang; V M Weaver
Journal:  Integr Biol (Camb)       Date:  2015-05-11       Impact factor: 2.192

4.  Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Authors:  Chanitra Thuwajit; Peti Thuwajit; Pranisa Jamjantra; Chawalit Pairojkul; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Junya Ono; Shoichiro Ohta; Kiminori Fujimoto; Kenji Izuhara
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

5.  Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.

Authors:  Ken Takai; Annie Le; Valerie M Weaver; Zena Werb
Journal:  Oncotarget       Date:  2016-12-13

6.  MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.

Authors:  Hongyan Yuan; Xiaoyi Wang; Jin Lu; Qiongsi Zhang; Irina Brandina; Ilya Alexandrov; Robert I Glazer
Journal:  Oncotarget       Date:  2018-01-15

7.  Disrupted circadian clocks and altered tissue mechanics in primary human breast tumours.

Authors:  Eleanor Broadberry; James McConnell; Jack Williams; Nan Yang; Egor Zindy; Angela Leek; Rachel Waddington; Leena Joseph; Miles Howe; Qing-Jun Meng; Charles H Streuli
Journal:  Breast Cancer Res       Date:  2018-10-22       Impact factor: 6.466

Review 8.  Breast cancer lung metastasis: Molecular biology and therapeutic implications.

Authors:  Liting Jin; Bingchen Han; Emily Siegel; Yukun Cui; Armando Giuliano; Xiaojiang Cui
Journal:  Cancer Biol Ther       Date:  2018-04-30       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.